Today: 19 May 2026
Infosys Share Price Today (23 Dec 2025): INFY Stock Dips on BSE After ADR Whiplash, Buyback Completion, and Fresh Q3 Results Catalyst
23 December 2025
6 mins read

Infosys Share Price Today (23 Dec 2025): INFY Stock Dips on BSE After ADR Whiplash, Buyback Completion, and Fresh Q3 Results Catalyst

Infosys Limited (INFY) is back in the spotlight on Tuesday, December 23, 2025, with traders on BSE Ltd. tracking a pullback in Indian IT stocks, while investors continue to digest an unusual burst of volatility in the company’s U.S.-listed ADRs, a newly disclosed legal settlement at its U.S. subsidiary, and the after-effects of its just-completed ₹18,000 crore buyback.

By midday, Infosys shares were trading lower on the BSE, broadly in line with weakness across the IT pack, as year-end positioning and macro signals (especially the rupee and U.S. rate expectations) shaped sentiment.

Infosys share price on BSE today: what the tape is saying

On 23 Dec 2025, Infosys traded around the ₹1,660–₹1,670 zone in late morning/around midday, down roughly 1%–2% on the day. The stock’s intraday range sat roughly in the mid-₹1,650s to high-₹1,670s, while the 52-week range remained wide at about ₹1,307 to ₹1,983, underlining how much the name has swung during 2025.

This dip follows a strong prior session: on Monday, December 22, Infosys rallied about 3% on the BSE and touched the ₹1,690+ area intraday amid headline-driven momentum (more on that below).

The “Wall Street mystery” that spilled into India: Infosys ADR spike and trading halts

The biggest attention magnet in the last few sessions wasn’t a new mega-deal or guidance upgrade—it was a sudden surge in Infosys’ American Depositary Receipts (ADRs) on the New York Stock Exchange.

On Friday, December 19, Infosys ADRs jumped dramatically intraday—reports put the peak move at roughly 50%–56%, triggering volatility-related trading pauses/halts on the NYSE.

Infosys’ official line: no undisclosed material event

Infosys issued a formal clarification stating it had observed volatility in its ADR price on Dec. 19, 2025, and that the moves triggered two volatility pauses, but emphasized there were no material events requiring disclosure under SEBI’s listing regulations.

What likely happened (working theory, not a proven fact)

Market commentary in the U.S. framed the move as potentially driven by market-structure mechanics—thin liquidity, derivatives positioning, and forced buying dynamics—rather than a fundamental revaluation of the business overnight. One report described the episode as a “mystery move,” while another attributed it to squeeze-like conditions tied to the ADR conversion and options activity. These explanations are plausible, but the key point for investors is that Infosys itself did not attribute the spike to a new corporate development. MarketWatch+2MarketWatch+2

After the spike: ADRs cooled fast

By Monday, December 22, Infosys ADRs fell sharply (down about 5% in one report), highlighting how quickly the U.S. surge mean-reverted.

For India-listed shareholders, that sequence matters: when a stock does something “weird” in one venue (like ADRs in the U.S.), it can briefly lift attention and volumes at home—but the longer-term anchor still tends to be earnings, guidance, deal momentum, and margins.

Another real headline: Infosys McCamish $17.5 million settlement got final court approval

Alongside the ADR story, Infosys also disclosed a concrete development involving Infosys McCamish Systems LLC, its U.S.-based subsidiary.

In a company statement dated December 20, 2025, Infosys said McCamish agreed to pay $17.5 million into a settlement fund tied to class action lawsuits, and that a U.S. court granted final approval on December 18, 2025. Infosys noted that if the settlement isn’t appealed within 30 days, it becomes effective and resolves the allegations without admission of liability.

Indian markets clearly noticed. A Business Standard report linked Monday’s move in Infosys shares to the settlement approval news, with the stock rising over 3% and marking its best intraday jump in weeks while touching levels last seen earlier in 2025.

Buyback is done: what the ₹18,000 crore repurchase changed (and what it didn’t)

Infosys’ shareholder return machine also remained part of the narrative in December, because the company has now completed its large buyback.

Key buyback facts (now in the record)

Regulatory disclosures show:

  • The buyback ran through the tender route, opening Nov. 20, 2025 and closing Nov. 26, 2025.
  • Infosys bought back 10 crore (100,000,000) equity shares at ₹1,800 per share.
  • The issue was heavily subscribed, with total valid shares tendered implying a response of roughly 825% in the post-buyback public announcement.
  • Equity share capital reduced from 4,15,44,01,349 shares (pre) to 4,05,46,24,409 shares (post), per the extinguishment disclosure.
  • For the buyback process, BSE Limited was the designated stock exchange.

Why buybacks matter for the stock

Mechanically, a lower share count can support earnings per share (EPS) over time—assuming profits hold up—because the same earnings are divided across fewer shares. Buybacks can also signal confidence in capital allocation and reduce free float marginally.

But it’s not magic: buybacks don’t automatically fix demand softness in IT services, and they don’t remove execution risk. They simply reshape the capital structure and return cash to shareholders.

A quirky but important side effect is also visible in the post-buyback shareholding data: promoter holding as a percentage rose (because the denominator—the total shares outstanding—fell), even if promoter shares themselves didn’t necessarily increase.

Next big catalyst: Infosys Q3FY26 results on January 14, 2026

Looking ahead, the next fundamental checkpoint is close enough to matter for positioning.

Infosys is scheduled to announce Q3FY26 results on January 14, 2026. The company also disclosed that its Board will meet January 13 and 14 to consider and approve results for the quarter and nine months ended December 31, 2025, and that it will host investor/analyst calls on January 14.

The setup: guidance tightening already happened in Q2

In its Q2FY26 communication, Infosys guided for FY26 revenue growth of 2%–3% in constant currency and operating margin of 20%–22%.

That guidance is now the baseline investors will benchmark against in January—especially after a year where global enterprise tech spending has been selective and heavily scrutinized for ROI (return on investment). Whether Infosys raises, holds, or trims its outlook is likely to be a major driver of the next multi-week trend.

Analyst forecasts and target prices: “Buy” consensus, but not an obvious runaway upside

“Forecast” can mean many things online (some of it… shall we say… numerology with a suit on). For a Google News–style investor read, the most defensible approach is to stick to sell-side analyst consensus and clearly label what it is.

India-listed INFY: targets cluster in a relatively tight band

Different aggregators show different consensus snapshots:

  • Trendlyne showed an average target of ₹1,639.18, implying a slight downside from the prevailing price area on Dec. 23.
  • Investing.com’s consensus estimates page showed an average target around ₹1,729.5, with a high estimate near ₹2,150 and low near ₹1,470, and a consensus rating described as “Buy” (with buys dominating, alongside holds and a small number of sells). Investing.com
  • Business Standard, citing Bloomberg-compiled analyst coverage, reported an average 12‑month target around ₹1,727, and a rating distribution with buys dominating over holds and sells.

The practical takeaway: Street expectations don’t scream “massively undervalued” at current levels—they read more like a stock priced for “steady compounding if execution stays clean,” with upside dependent on earnings delivery, margin protection, and deal ramps.

ADR investors: volatility reminded everyone to separate structure from story

In the U.S., the ADR spike-and-cool-off sequence is a reminder that liquidity, options flows, and market mechanics can temporarily overpower fundamentals—especially around year-end. The company’s clarification and the fast retracement reinforced the idea that the ADR event was not a sudden fundamental repricing.

The macro backdrop on Dec. 23: IT pullback and year-end market texture

Infosys didn’t fall in a vacuum today. Reuters described Indian benchmarks as flat-to-muted on Dec. 23, weighed by a pullback in IT shares after a recent rally, with trading volumes also thinning into year-end.

For IT services exporters like Infosys, investors are also watching the rupee and U.S. rate expectations because they can influence:

  • reported rupee revenue translation,
  • global risk appetite,
  • and the spending mood of large U.S. and European clients.

That context helps explain why Infosys can move sharply even when there’s no single “company-specific” trigger dominating the tape.

Bottom line for Infosys stock on BSE: what matters next

As of 23 December 2025, Infosys stock is being pulled by three competing forces:

  1. Headline gravity (ADR volatility + clarification; McCamish settlement approval) that drove attention and short-term flows.
  2. Capital-return structure (completed buyback, reduced share count) that supports the shareholder-return narrative but doesn’t replace earnings growth.
  3. The real catalyst queue (Q3 results on Jan. 14, 2026; guidance and commentary) which will likely decide whether the stock trends or chops.

For investors and traders following Infosys on BSE Ltd., the next few weeks are less about the one-off ADR mystery and more about whether Infosys can translate its deal momentum and AI positioning into durable revenue growth and stable margins—and whether management’s commentary in January supports a more confident FY26 finish.

Stock Market Today

  • Ameren (AEE) Valuation Reevaluation Amid Recent Price Drop
    May 19, 2026, 3:27 AM EDT. Ameren (AEE) shares dipped 5.6% over the past month, prompting a reassessment of its valuation. Year to date, the stock has gained 5.5%, but recent declines reflect short-term market volatility for this regulated U.S. utility. Using the Dividend Discount Model, Ameren is estimated to be 12% overvalued with an intrinsic value near $94.92 versus a current share price of $106.36. Its price-to-earnings ratio stands at 19.31x, above the Integrated Utilities industry average of 18.12x but below the peer average of 22.03x. These mixed signals highlight the need for investors to weigh Ameren's moderate dividend growth prospects and regulatory role against recent market fluctuations.

Latest articles

Nasdaq gives up after-hours gains as oil and yields weigh on Wall Street rally

Nasdaq gives up after-hours gains as oil and yields weigh on Wall Street rally

19 May 2026
Dominion Energy shares jumped 9.4% after agreeing to an all-stock merger with NextEra Energy, whose shares fell 4.6%. The S&P 500 slipped 0.1% and the Nasdaq dropped 0.5% as investors sold technology stocks amid rising Treasury yields and oil prices. Nvidia fell 1.4% ahead of earnings. U.S. crude settled at $107.37, and the 10-year Treasury yield reached 4.59%.
XP Shares Slip Post-Q1, Buyback Fails to Sway Investors

XP Shares Slip Post-Q1, Buyback Fails to Sway Investors

19 May 2026
XP Inc.’s U.S.-listed shares fell 3.78% in after-hours trading Monday after reporting higher Q1 profit but weaker net inflows and a lower retail take rate. Net income rose 7% to 1.32 billion reais, but net inflow dropped to 14 billion reais from 24 billion a year earlier. The company declared a $0.20 dividend and announced a new CFO, Gustavo Alejo Viviani, starting August 3.
LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

19 May 2026
Publicis Groupe agreed to buy LiveRamp Holdings for $38.50 a share in cash, valuing the U.S. data-collaboration firm at $2.546 billion. LiveRamp stock jumped to $37.77 on the news, while the broader market fell. LiveRamp reported fiscal Q4 revenue of $206 million, up 9% from a year earlier. Publicis said the deal will boost its adjusted earnings per share from the first year after closing.

Popular

Sunshine Biopharma Shares Volatile After $6M Deal, 50-Cent Mark in Focus

Sunshine Biopharma Shares Volatile After $6M Deal, 50-Cent Mark in Focus

19 May 2026
Sunshine Biopharma shares surged as much as 516% before settling up 78% at $0.51 in heavy after-hours Nasdaq trading Monday, following a $6 million public offering priced at $0.50 per unit. More than 436 million shares changed hands, far exceeding the company’s 5 million shares outstanding. The deal includes 12 million units with warrants, raising dilution concerns. Closing is expected around May 19.
Jupiter Wagons Share Price Surges as Promoter Raises Stake: Key News, Budget 2026 Tailwinds, and Analyst Targets (23 Dec 2025)
Previous Story

Jupiter Wagons Share Price Surges as Promoter Raises Stake: Key News, Budget 2026 Tailwinds, and Analyst Targets (23 Dec 2025)

Rio Tinto plc Stock (RIO.L) Hits a 52-Week High: What’s Driving the Rally, 2026 Guidance, and Analyst Forecasts (Dec. 23, 2025)
Next Story

Rio Tinto plc Stock (RIO.L) Hits a 52-Week High: What’s Driving the Rally, 2026 Guidance, and Analyst Forecasts (Dec. 23, 2025)

Go toTop